Cardiopulmonary bypass (CPB) stands as a crucial medical intervention utilized during cardiac surgeries, temporarily assuming the vital functions of the heart and lungs. This intricate procedure involves rerouting the patient's blood away from the heart and lungs, employing a heart-lung machine to take charge of oxygenation and blood circulation throughout the body. Acting as a surrogate for natural physiological processes, the machine effectively removes carbon dioxide and adds oxygen to the blood. By inducing a state of motionlessness and bloodlessness in the heart, CPB enables surgeons to conduct intricate cardiac procedures that would otherwise be challenging or impractical. While integral to various cardiac interventions, the application of cardiopulmonary bypass comes with inherent risks. Ongoing research is dedicated to refining CPB techniques to minimize potential complications, ensuring improved patient outcomes. The evolution of this technology has significantly propelled the field of cardiac surgery, revolutionizing the landscape of life-saving interventions and enhancing the overall success of complex cardiac procedures.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation